PTC Therapeutics Inc logo

PTC Therapeutics Inc

$ 41.87 +0.32 (+0.77%) 10:39 AM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 3.06B
Enterprise V:
$ 3.22B
Volume:
54.38K
Avg Vol (2M):
662.43K
Also Trade In:
Volume:
54.38K
Market Cap $:
3.06B
PE Ratio:
At Loss
Avg Vol (2-Month):
662.43K
Enterprise Value $:
3.22B
PB Ratio:
0
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
Name Current Vs Industry Vs History
Cash-To-Debt 0.7
Equity-to-Asset -0.14
Debt-to-Equity -1.83
Debt-to-EBITDA -1.23
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.62
Distress
Grey
Safe
Beneish M-Score -2.74
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 76.52
9-Day RSI 62.81
14-Day RSI 53.69
6-1 Month Momentum % 29.75
12-1 Month Momentum % 5.01

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.23
Quick Ratio 1.2
Cash Ratio 0.69
Days Inventory 129.65
Days Sales Outstanding 63.8
Days Payable 180.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.9

Financials (Next Earnings Date:2023-02-22 Est.)

PTCT's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:PTCT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 696.617
EPS (TTM) ($) -7.47
Beta 0.15
Volatility % 55.58
14-Day RSI 53.69
14-Day ATR ($) 1.941215
20-Day SMA ($) 38.3425
12-1 Month Momentum % 5.01
52-Week Range ($) 25.01 - 55.5799
Shares Outstanding (Mil) 72.98

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PTC Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

PTC Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.